Denmark· DK-28105388714

Liprolog KwikPen

A insulin lispro product containing insulin lispro, registered in Denmark by Eli Lilly Netherland B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A10AB04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedLiprolog KwikPenATCA10AB04REGISTER NO.DK-28105388714PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Insulin lispro is registered in 11 of 19 countries.

Countries holding a registration under ATC A10AB04 (insulin lispro), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose

Insulin lispro · ATC A10AB04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Insulin lispro
Manufacturer
Eli Lilly Netherland B.V.
Country
Denmark (DK)
ATC code
A10AB04
ATC class
Insulin lispro
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105388714

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

434 interactions on record for insulin lispro.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Insulin lispro · interactions on record

434 records

  • 15 severe
  • 368 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b22098d6-5bcf-4df8-ba06-99794cf14177
GET /v1/drugs/b22098d6-5bcf-4df8-ba06-99794cf14177?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning i fyldt pen",
  "source": "dkma",
  "strength": "200 E/ml",
  "auth_role": "MOD",
  "dk_drugid": "28105388714",
  "substance": "Insulin lispro",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "41913"
}

See everything about insulin lispro.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.